American International Group’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-21,256
| Closed | -$200K | – | 3170 |
|
|
2020
Q3 | $200K | Sell |
21,256
-899
| -4% | -$8.54K | ﹤0.01% | 2144 |
|
|
2020
Q2 | $169K | Sell |
22,155
-1,027
| -4% | -$7.86K | ﹤0.01% | 2225 |
|
|
2020
Q1 | $143K | Sell |
23,182
-1,152
| -5% | -$10.1K | ﹤0.01% | 2103 |
|
|
2019
Q4 | $296K | Sell |
24,334
-655
| -3% | -$7.16K | ﹤0.01% | 1987 |
|
|
2019
Q3 | $289K | Sell |
24,989
-265
| -1% | -$2.79K | ﹤0.01% | 1962 |
|
|
2019
Q2 | $252K | Sell |
25,254
-723
| -3% | -$7.8K | ﹤0.01% | 2090 |
|
|
2019
Q1 | $335K | Sell |
25,977
-684
| -3% | -$10.2K | ﹤0.01% | 1928 |
|
|
2018
Q4 | $405K | Sell |
26,661
-308
| -1% | -$5.87K | ﹤0.01% | 1799 |
|
|
2018
Q3 | $539K | Buy |
26,969
+527
| +2% | +$12K | ﹤0.01% | 1851 |
|
|
2018
Q2 | $516K | Buy |
26,442
+4,019
| +18% | +$88.9K | ﹤0.01% | 1818 |
|
|
2018
Q1 | $452K | Sell |
22,423
-5,501
| -20% | -$93.1K | ﹤0.01% | 1791 |
|
|
2017
Q4 | $370K | Buy |
27,924
+122
| +0.4% | +$1.84K | ﹤0.01% | 1962 |
|
|
2017
Q3 | $513K | Buy |
27,802
+1,540
| +6% | +$28.7K | ﹤0.01% | 1747 |
|
|
2017
Q2 | $483K | Buy |
26,262
+4,786
| +22% | +$94.8K | ﹤0.01% | 1731 |
|
|
2017
Q1 | $484K | Sell |
21,476
-3,977
| -16% | -$95.2K | ﹤0.01% | 1617 |
|
|
2016
Q4 | $886K | Sell |
25,453
-360
| -1% | -$10.8K | ﹤0.01% | 1300 |
|
|
2016
Q3 | $633K | Sell |
25,813
-89
| -0.3% | -$2.22K | ﹤0.01% | 1470 |
|
|
2016
Q2 | $620K | Sell |
25,902
-304
| -1% | -$6.97K | ﹤0.01% | 1466 |
|
|
2016
Q1 | $613K | Buy |
26,206
+7,743
| +42% | +$184K | ﹤0.01% | 1845 |
|
|
2015
Q4 | $558K | Sell |
18,463
-431
| -2% | -$13.9K | ﹤0.01% | 1940 |
|
|
2015
Q3 | $751K | Buy |
18,894
+553
| +3% | +$34.3K | ﹤0.01% | 1662 |
|
|
2015
Q2 | $1.27M | Buy |
18,341
+4,362
| +31% | +$274K | 0.01% | 1404 |
|
|
2015
Q1 | $764K | Buy |
13,979
+200
| +1% | +$9.53K | ﹤0.01% | 1823 |
|
|
2014
Q4 | $587K | Sell |
13,779
-546
| -4% | -$19.7K | ﹤0.01% | 1992 |
|
|
2014
Q3 | $457K | Sell |
14,325
-11
| -0.1% | -$235 | ﹤0.01% | 2223 |
|
|
2014
Q2 | $297K | Sell |
14,336
-1,034
| -7% | -$19.1K | ﹤0.01% | 2636 |
|
|
2014
Q1 | $297K | Buy |
15,370
+1,052
| +7% | +$22.3K | ﹤0.01% | 2492 |
|
|
2013
Q4 | $347K | Sell |
14,318
-144
| -1% | -$3.39K | ﹤0.01% | 2301 |
|
|
2013
Q3 | $311K | Sell |
14,462
-248
| -2% | -$5.86K | ﹤0.01% | 2331 |
|
|
2013
Q2 | $327K | Buy |
+14,710
| New | +$324K | ﹤0.01% | 2166 |
|
American International Group's AMAG Position: Q4 2020 in Review
American International Group sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 21,256 shares — an estimated $200K sold.
American International Group first reported a position in AMAG in Q2 2013 and held it in 30 quarters. The position peaked at $1.27M in Q2 2015. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.
- American International Group reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- American International Group sold 21,256 AMAG Pharmaceuticals shares in Q4 2020, an estimated $200K.
- American International Group first reported a position in AMAG Pharmaceuticals in Q2 2013 and held it in 30 quarters.
- American International Group's AMAG Pharmaceuticals position peaked at $1.27M in Q2 2015.
- 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.
Based on American International Group's 13F filing for Q4 2020, filed 12 Feb 2021.